The global light therapy market is estimated to be valued at US$ 989.2 million in 2023 and is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030).
Analysts’ Views on Global Light Therapy Market:
Light therapy is used for the treatment of medical conditions such as neurological disorders, skin disorders, jaundice, and others. Thus, an increase in the prevalence of neurological disorders will lead to increased demand for light therapy devices, which will contribute to the growth of the global light therapy market over the forecast period. For instance, according to the Pan American Health Organization’s updates, in region wide 2019, there were 8.2 million years lived with disability (YLDs), 3.1 million years lost to early death (YLLs), and 5.1 million years lost to life due to pregnancy (YLLs).
Figure 1. Global Light Therapy Market Share (%), By Light Type, 2023
To learn more about this report, request sample copy
Global Light Therapy Market– Drivers
Figure 2. Global Light Therapy Market Share (%), By Region, 2023
To learn more about this report, request sample copy
Global Light Therapy Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global light therapy market over the forecast period. The global light therapy market is expected to witness significant growth in the coming years, driven by positive results from research activities in the region. For instance, according to Clinicaltrials.gov, the Portland VA Medical Center and Oregon Health and Science University initiated a study in April 2022 that is anticipated to be finished in August 2026. The purpose of this study was to determine whether morning bright light therapy could possibly enhance sleep in veterans with traumatic brain injuries and evaluate its potential efficacy.
Global Light Therapy Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, are facing problems with the transportation of things from one place to another.
However, the COVID-19 pandemic had a positive impact on the global light therapy market, owing to an increase in the conduct of clinical trials to determine the safety and efficacy of light therapy on the recovery of COVID-19 patients. For instance, in October 2020, Vielight Inc., evelops transcranial-intranasal photobiomodulation (PBM) technology, initiated clinical trials to test whether photobiomodulation, i.e., a combination of intranasally delivered LED-based red light and LED-based near-infrared (NIR) light to the body, may accelerate the recovery of COVID-19 patients. The research is based on the finding that photobiomodulation leads to the activation of the immune system and reduces inflammation. Thus, photobiomodulation may be effective in inhibiting the replication of coronaviruses. Such research and development activities are expected to support growth of the market over the forecast period.
Light Therapy Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2021 | Market Size in 2023: | US$ 989.2 Mn |
Historical Data for: | 2018 To 2021 | Forecast Period: | 2023 To 2030 |
Forecast Period 2023 to 2030 CAGR: | 5.2% | 2030 Value Projection: | US$ 1410.9 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Koninklijke Philips N.V., Verilux, Inc., Northern Light Technology, TheraLight, LLC, Zepter International, Photomedex Inc., Beurer GmbH, Nature Bright, Lucimed SA, PhotonMD, Inc., BioPhotas, Chal-Tec GmbH, Johnson & Johnson, and Carex Health Brands Inc. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Global Light Therapy Market Segmentation:
The global light therapy market report is segmented into by product type, by light type, by end user, and by region.
Among all the segmentation, the light type segment is expected to dominate the market over the forecast period and this is attributed to the increasing adoption of inorganic growth strategies and the rise in research and development activities.
Global Light Therapy Market- Cross Sectional Analysis:
The market studies will be supported by growing research and development studies demonstrating the effectiveness of red light therapy in treating various ailments in the Asia Pacific region. Thus, the red light type segment is expected to offer a lucrative growth in this region in near future. For instance, according to clinicaltrials.gov, the Zhongshan Ophthalmic Center at Sun Yat-sen University started a study in March 2021 to assess the adjunctive effect of repeated low-level red light therapy (RLRL) and orthokeratology (ortho-k) on myopia control in ortho-k non-responders who had received ortho-k treatment but were still experiencing rapid myopia progression. The outcomes of such research investigations will therefore improve its flexibility, resulting in lucrative market growth.
Global Light Therapy Market: Key Developments
Global Light Therapy Market: Key Trends
Global Light Therapy Market: Restraint
Global Light Therapy Market - Key Players
Major players operating in the global light therapy market include Koninklijke Philips N.V., Verilux, Inc., Northern Light Technology, TheraLight, LLC, Zepter International, Photomedex Inc., Beurer GmbH, Nature Bright, Lucimed SA, PhotonMD, Inc., BioPhotas, Chal-Tec GmbH, Johnson & Johnson, and Carex Health Brands Inc.
*Definition: Light therapy involves the use of natural light or any form of equivalent light for the treatment of certain conditions such as skin disorders (psoriasis and vitiligo), neurological disorders (anxiety, depression, seasonal affective disorder (SAD), mood, and sleep disorders), some cancers and precancerous conditions hyperbilirubinemia, etc.
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients